117 S631 IS: COVID–19 Mental Health Research Act U.S. Senate 2021-03-09 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.

II 117th CONGRESS1st Session S. 631 IN THE SENATE OF THE UNITED STATES March 9, 2021 Ms. Klobuchar (for herself and Mr. Kaine) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions A BILL To direct the Secretary of Health and Human Services, acting through the Director of the National Institute of Mental Health, to conduct or support research on the mental health consequences of SARS–CoV–2 or COVID–19, and for other purposes.

1.

Short title

This Act may be cited as the COVID–19 Mental Health Research Act.

2.

Research on the mental health impact of COVID–19

(a)

In general

The Secretary of Health and Human Services (in this section referred to as the Secretary), acting through the Director of the National Institute of Mental Health, shall conduct or support research on the mental health consequences of SARS–CoV–2 or COVID–19. (b)

Use of funds

Research under subsection (a) may include— (1)research on the mental health impact of SARS–CoV–2 or COVID–19 on health care providers, including— (A)traumatic stress; (B)psychological distress; (C)psychiatric disorders; and (D)longer-term stress, including burnout; (2)research on the impact of SARS–CoV–2 or COVID–19 stressors on mental health over time; (3)research to strengthen the mental health response to SARS–CoV–2 or COVID–19, including adapting to and maintaining or providing additional services for new or increasing mental health needs; (4)research on the reach, efficiency, effectiveness, and quality of digital mental health interventions; (5)research on the effectiveness of strategies for implementation and delivery of evidence-based mental health interventions and services for underserved populations; (6)research on suicide prevention; (7)research on the impact of SARS–CoV–2 or COVID–19 on the mental health of specific populations, including children and adolescents, women, older adults, individuals with disabilities, and members of racial and ethnic minority groups; and (8)research on the impact of SARS–CoV–2 or COVID–19 on the mental health of individuals experiencing long-term symptoms or side effects after infection. (c)

Research coordination

The Secretary shall coordinate activities under this section with similar activities conducted by national research institutes and centers of the National Institutes of Health to the extent that such institutes and centers have responsibilities that are related to the mental health consequences of SARS–CoV–2 or COVID–19. (d)

Authorization of appropriations

To carry out this section, there is authorized to be appropriated $100,000,000 for each of fiscal years 2022 through 2026, to remain available until expended. (e)

Supplement not supplant

Amounts made available to carry out this section shall be used to supplement, and not supplant, other funding made available to the National Institute of Mental Health.